Global Tafamidis Drugs Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Tafamidis is a pharmaceutical drug prescribed primarily for the treatment of transthyretin amyloidosis(ATTR),a rare and debilitating condition characterized by the abnormal accumulation of transthyretin protein in various tissues.By stabilizing transthyretin tetramers,Tafamidis helps prevent the formation of amyloid fibrils,which are the hallmark of the disease and lead to organ dysfunction,particularly affecting the heart and nerves.
The global Tafamidis Drugs market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Tafamidis Drugs Industry Forecast” looks at past sales and reviews total world Tafamidis Drugs sales in 2023, providing a comprehensive analysis by region and market sector of projected Tafamidis Drugs sales for 2024 through 2030. With Tafamidis Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tafamidis Drugs industry.
This Insight Report provides a comprehensive analysis of the global Tafamidis Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tafamidis Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tafamidis Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tafamidis Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tafamidis Drugs.
United States market for Tafamidis Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Tafamidis Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Tafamidis Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Tafamidis Drugs players cover Pfizer, Qilu pharmaceutical, Chia Tai Tianqing Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Tafamidis Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Tafamidis Drugs market?
What factors are driving Tafamidis Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Tafamidis Drugs market opportunities vary by end market size?
How does Tafamidis Drugs break out by Type, by Application?
Tafamidis is a pharmaceutical drug prescribed primarily for the treatment of transthyretin amyloidosis(ATTR),a rare and debilitating condition characterized by the abnormal accumulation of transthyretin protein in various tissues.By stabilizing transthyretin tetramers,Tafamidis helps prevent the formation of amyloid fibrils,which are the hallmark of the disease and lead to organ dysfunction,particularly affecting the heart and nerves.
The global Tafamidis Drugs market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Tafamidis Drugs Industry Forecast” looks at past sales and reviews total world Tafamidis Drugs sales in 2023, providing a comprehensive analysis by region and market sector of projected Tafamidis Drugs sales for 2024 through 2030. With Tafamidis Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tafamidis Drugs industry.
This Insight Report provides a comprehensive analysis of the global Tafamidis Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tafamidis Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tafamidis Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tafamidis Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tafamidis Drugs.
United States market for Tafamidis Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Tafamidis Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Tafamidis Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Tafamidis Drugs players cover Pfizer, Qilu pharmaceutical, Chia Tai Tianqing Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Tafamidis Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Tafamidis Free Acid
- Tafamidis Meglumine
- ATTR-PN
- ATTR-CM
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Qilu pharmaceutical
- Chia Tai Tianqing Pharmaceutical
What is the 10-year outlook for the global Tafamidis Drugs market?
What factors are driving Tafamidis Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Tafamidis Drugs market opportunities vary by end market size?
How does Tafamidis Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tafamidis Drugs Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Tafamidis Drugs by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Tafamidis Drugs by Country/Region, 2019, 2023 & 2030
2.2 Tafamidis Drugs Segment by Type
2.2.1 Tafamidis Free Acid
2.2.2 Tafamidis Meglumine
2.3 Tafamidis Drugs Sales by Type
2.3.1 Global Tafamidis Drugs Sales Market Share by Type (2019-2024)
2.3.2 Global Tafamidis Drugs Revenue and Market Share by Type (2019-2024)
2.3.3 Global Tafamidis Drugs Sale Price by Type (2019-2024)
2.4 Tafamidis Drugs Segment by Application
2.4.1 ATTR-PN
2.4.2 ATTR-CM
2.4.3 Other
2.5 Tafamidis Drugs Sales by Application
2.5.1 Global Tafamidis Drugs Sale Market Share by Application (2019-2024)
2.5.2 Global Tafamidis Drugs Revenue and Market Share by Application (2019-2024)
2.5.3 Global Tafamidis Drugs Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Tafamidis Drugs Breakdown Data by Company
3.1.1 Global Tafamidis Drugs Annual Sales by Company (2019-2024)
3.1.2 Global Tafamidis Drugs Sales Market Share by Company (2019-2024)
3.2 Global Tafamidis Drugs Annual Revenue by Company (2019-2024)
3.2.1 Global Tafamidis Drugs Revenue by Company (2019-2024)
3.2.2 Global Tafamidis Drugs Revenue Market Share by Company (2019-2024)
3.3 Global Tafamidis Drugs Sale Price by Company
3.4 Key Manufacturers Tafamidis Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tafamidis Drugs Product Location Distribution
3.4.2 Players Tafamidis Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TAFAMIDIS DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Tafamidis Drugs Market Size by Geographic Region (2019-2024)
4.1.1 Global Tafamidis Drugs Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Tafamidis Drugs Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Tafamidis Drugs Market Size by Country/Region (2019-2024)
4.2.1 Global Tafamidis Drugs Annual Sales by Country/Region (2019-2024)
4.2.2 Global Tafamidis Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas Tafamidis Drugs Sales Growth
4.4 APAC Tafamidis Drugs Sales Growth
4.5 Europe Tafamidis Drugs Sales Growth
4.6 Middle East & Africa Tafamidis Drugs Sales Growth
5 AMERICAS
5.1 Americas Tafamidis Drugs Sales by Country
5.1.1 Americas Tafamidis Drugs Sales by Country (2019-2024)
5.1.2 Americas Tafamidis Drugs Revenue by Country (2019-2024)
5.2 Americas Tafamidis Drugs Sales by Type (2019-2024)
5.3 Americas Tafamidis Drugs Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tafamidis Drugs Sales by Region
6.1.1 APAC Tafamidis Drugs Sales by Region (2019-2024)
6.1.2 APAC Tafamidis Drugs Revenue by Region (2019-2024)
6.2 APAC Tafamidis Drugs Sales by Type (2019-2024)
6.3 APAC Tafamidis Drugs Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Tafamidis Drugs by Country
7.1.1 Europe Tafamidis Drugs Sales by Country (2019-2024)
7.1.2 Europe Tafamidis Drugs Revenue by Country (2019-2024)
7.2 Europe Tafamidis Drugs Sales by Type (2019-2024)
7.3 Europe Tafamidis Drugs Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tafamidis Drugs by Country
8.1.1 Middle East & Africa Tafamidis Drugs Sales by Country (2019-2024)
8.1.2 Middle East & Africa Tafamidis Drugs Revenue by Country (2019-2024)
8.2 Middle East & Africa Tafamidis Drugs Sales by Type (2019-2024)
8.3 Middle East & Africa Tafamidis Drugs Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tafamidis Drugs
10.3 Manufacturing Process Analysis of Tafamidis Drugs
10.4 Industry Chain Structure of Tafamidis Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tafamidis Drugs Distributors
11.3 Tafamidis Drugs Customer
12 WORLD FORECAST REVIEW FOR TAFAMIDIS DRUGS BY GEOGRAPHIC REGION
12.1 Global Tafamidis Drugs Market Size Forecast by Region
12.1.1 Global Tafamidis Drugs Forecast by Region (2025-2030)
12.1.2 Global Tafamidis Drugs Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Tafamidis Drugs Forecast by Type (2025-2030)
12.7 Global Tafamidis Drugs Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Tafamidis Drugs Product Portfolios and Specifications
13.1.3 Pfizer Tafamidis Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Qilu pharmaceutical
13.2.1 Qilu pharmaceutical Company Information
13.2.2 Qilu pharmaceutical Tafamidis Drugs Product Portfolios and Specifications
13.2.3 Qilu pharmaceutical Tafamidis Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Qilu pharmaceutical Main Business Overview
13.2.5 Qilu pharmaceutical Latest Developments
13.3 Chia Tai Tianqing Pharmaceutical
13.3.1 Chia Tai Tianqing Pharmaceutical Company Information
13.3.2 Chia Tai Tianqing Pharmaceutical Tafamidis Drugs Product Portfolios and Specifications
13.3.3 Chia Tai Tianqing Pharmaceutical Tafamidis Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Chia Tai Tianqing Pharmaceutical Main Business Overview
13.3.5 Chia Tai Tianqing Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1.Tafamidis Drugs Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2.Tafamidis Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players ofTafamidisFree Acid
Table 4. Major Players ofTafamidis Meglumine
Table 5. GlobalTafamidis Drugs Sales byType (2019-2024) & (K Units)
Table 6. GlobalTafamidis Drugs Sales Market Share byType (2019-2024)
Table 7. GlobalTafamidis Drugs Revenue byType (2019-2024) & ($ million)
Table 8. GlobalTafamidis Drugs Revenue Market Share byType (2019-2024)
Table 9. GlobalTafamidis Drugs Sale Price byType (2019-2024) & (US$/Unit)
Table 10. GlobalTafamidis Drugs Sale by Application (2019-2024) & (K Units)
Table 11. GlobalTafamidis Drugs Sale Market Share by Application (2019-2024)
Table 12. GlobalTafamidis Drugs Revenue by Application (2019-2024) & ($ million)
Table 13. GlobalTafamidis Drugs Revenue Market Share by Application (2019-2024)
Table 14. GlobalTafamidis Drugs Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. GlobalTafamidis Drugs Sales by Company (2019-2024) & (K Units)
Table 16. GlobalTafamidis Drugs Sales Market Share by Company (2019-2024)
Table 17. GlobalTafamidis Drugs Revenue by Company (2019-2024) & ($ millions)
Table 18. GlobalTafamidis Drugs Revenue Market Share by Company (2019-2024)
Table 19. GlobalTafamidis Drugs Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key ManufacturersTafamidis Drugs Producing Area Distribution and Sales Area
Table 21. PlayersTafamidis Drugs Products Offered
Table 22.Tafamidis Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. GlobalTafamidis Drugs Sales by Geographic Region (2019-2024) & (K Units)
Table 26. GlobalTafamidis Drugs Sales Market Share Geographic Region (2019-2024)
Table 27. GlobalTafamidis Drugs Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. GlobalTafamidis Drugs Revenue Market Share by Geographic Region (2019-2024)
Table 29. GlobalTafamidis Drugs Sales by Country/Region (2019-2024) & (K Units)
Table 30. GlobalTafamidis Drugs Sales Market Share by Country/Region (2019-2024)
Table 31. GlobalTafamidis Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. GlobalTafamidis Drugs Revenue Market Share by Country/Region (2019-2024)
Table 33. AmericasTafamidis Drugs Sales by Country (2019-2024) & (K Units)
Table 34. AmericasTafamidis Drugs Sales Market Share by Country (2019-2024)
Table 35. AmericasTafamidis Drugs Revenue by Country (2019-2024) & ($ millions)
Table 36. AmericasTafamidis Drugs Sales byType (2019-2024) & (K Units)
Table 37. AmericasTafamidis Drugs Sales by Application (2019-2024) & (K Units)
Table 38. APACTafamidis Drugs Sales by Region (2019-2024) & (K Units)
Table 39. APACTafamidis Drugs Sales Market Share by Region (2019-2024)
Table 40. APACTafamidis Drugs Revenue by Region (2019-2024) & ($ millions)
Table 41. APACTafamidis Drugs Sales byType (2019-2024) & (K Units)
Table 42. APACTafamidis Drugs Sales by Application (2019-2024) & (K Units)
Table 43. EuropeTafamidis Drugs Sales by Country (2019-2024) & (K Units)
Table 44. EuropeTafamidis Drugs Revenue by Country (2019-2024) & ($ millions)
Table 45. EuropeTafamidis Drugs Sales byType (2019-2024) & (K Units)
Table 46. EuropeTafamidis Drugs Sales by Application (2019-2024) & (K Units)
Table 47. Middle East & AfricaTafamidis Drugs Sales by Country (2019-2024) & (K Units)
Table 48. Middle East & AfricaTafamidis Drugs Revenue Market Share by Country (2019-2024)
Table 49. Middle East & AfricaTafamidis Drugs Sales byType (2019-2024) & (K Units)
Table 50. Middle East & AfricaTafamidis Drugs Sales by Application (2019-2024) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities ofTafamidis Drugs
Table 52. Key Market Challenges & Risks ofTafamidis Drugs
Table 53. Key IndustryTrends ofTafamidis Drugs
Table 54.Tafamidis Drugs Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56.Tafamidis Drugs Distributors List
Table 57.Tafamidis Drugs Customer List
Table 58. GlobalTafamidis Drugs SalesForecast by Region (2025-2030) & (K Units)
Table 59. GlobalTafamidis Drugs RevenueForecast by Region (2025-2030) & ($ millions)
Table 60. AmericasTafamidis Drugs SalesForecast by Country (2025-2030) & (K Units)
Table 61. AmericasTafamidis Drugs Annual RevenueForecast by Country (2025-2030) & ($ millions)
Table 62. APACTafamidis Drugs SalesForecast by Region (2025-2030) & (K Units)
Table 63. APACTafamidis Drugs Annual RevenueForecast by Region (2025-2030) & ($ millions)
Table 64. EuropeTafamidis Drugs SalesForecast by Country (2025-2030) & (K Units)
Table 65. EuropeTafamidis Drugs RevenueForecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & AfricaTafamidis Drugs SalesForecast by Country (2025-2030) & (K Units)
Table 67. Middle East & AfricaTafamidis Drugs RevenueForecast by Country (2025-2030) & ($ millions)
Table 68. GlobalTafamidis Drugs SalesForecast byType (2025-2030) & (K Units)
Table 69. GlobalTafamidis Drugs RevenueForecast byType (2025-2030) & ($ millions)
Table 70. GlobalTafamidis Drugs SalesForecast by Application (2025-2030) & (K Units)
Table 71. GlobalTafamidis Drugs RevenueForecast by Application (2025-2030) & ($ millions)
Table 72. Pfizer Basic Information,Tafamidis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 73. PfizerTafamidis Drugs Product Portfolios and Specifications
Table 74. PfizerTafamidis Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Pfizer Main Business
Table 76. Pfizer Latest Developments
Table 77. Qilu pharmaceutical Basic Information,Tafamidis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 78. Qilu pharmaceuticalTafamidis Drugs Product Portfolios and Specifications
Table 79. Qilu pharmaceuticalTafamidis Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Qilu pharmaceutical Main Business
Table 81. Qilu pharmaceutical Latest Developments
Table 82. ChiaTaiTianqing Pharmaceutical Basic Information,Tafamidis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. ChiaTaiTianqing PharmaceuticalTafamidis Drugs Product Portfolios and Specifications
Table 84. ChiaTaiTianqing PharmaceuticalTafamidis Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. ChiaTaiTianqing Pharmaceutical Main Business
Table 86. ChiaTaiTianqing Pharmaceutical Latest Developments
LIST OFFIGURES
Figure 1. Picture ofTafamidis Drugs
Figure 2.Tafamidis Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. GlobalTafamidis Drugs Sales Growth Rate 2019-2030 (K Units)
Figure 7. GlobalTafamidis Drugs Revenue Growth Rate 2019-2030 ($ millions)
Figure 8.Tafamidis Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9.Tafamidis Drugs Sales Market Share by Country/Region (2023)
Figure 10.Tafamidis Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture ofTafamidisFree Acid
Figure 12. Product Picture ofTafamidis Meglumine
Figure 13. GlobalTafamidis Drugs Sales Market Share byType in 2023
Figure 14. GlobalTafamidis Drugs Revenue Market Share byType (2019-2024)
Figure 15.Tafamidis Drugs Consumed in ATTR-PN
Figure 16. GlobalTafamidis Drugs Market: ATTR-PN (2019-2024) & (K Units)
Figure 17.Tafamidis Drugs Consumed in ATTR-CM
Figure 18. GlobalTafamidis Drugs Market: ATTR-CM (2019-2024) & (K Units)
Figure 19.Tafamidis Drugs Consumed in Other
Figure 20. GlobalTafamidis Drugs Market: Other (2019-2024) & (K Units)
Figure 21. GlobalTafamidis Drugs Sale Market Share by Application (2023)
Figure 22. GlobalTafamidis Drugs Revenue Market Share by Application in 2023
Figure 23.Tafamidis Drugs Sales by Company in 2023 (K Units)
Figure 24. GlobalTafamidis Drugs Sales Market Share by Company in 2023
Figure 25.Tafamidis Drugs Revenue by Company in 2023 ($ millions)
Figure 26. GlobalTafamidis Drugs Revenue Market Share by Company in 2023
Figure 27. GlobalTafamidis Drugs Sales Market Share by Geographic Region (2019-2024)
Figure 28. GlobalTafamidis Drugs Revenue Market Share by Geographic Region in 2023
Figure 29. AmericasTafamidis Drugs Sales 2019-2024 (K Units)
Figure 30. AmericasTafamidis Drugs Revenue 2019-2024 ($ millions)
Figure 31. APACTafamidis Drugs Sales 2019-2024 (K Units)
Figure 32. APACTafamidis Drugs Revenue 2019-2024 ($ millions)
Figure 33. EuropeTafamidis Drugs Sales 2019-2024 (K Units)
Figure 34. EuropeTafamidis Drugs Revenue 2019-2024 ($ millions)
Figure 35. Middle East & AfricaTafamidis Drugs Sales 2019-2024 (K Units)
Figure 36. Middle East & AfricaTafamidis Drugs Revenue 2019-2024 ($ millions)
Figure 37. AmericasTafamidis Drugs Sales Market Share by Country in 2023
Figure 38. AmericasTafamidis Drugs Revenue Market Share by Country (2019-2024)
Figure 39. AmericasTafamidis Drugs Sales Market Share byType (2019-2024)
Figure 40. AmericasTafamidis Drugs Sales Market Share by Application (2019-2024)
Figure 41. United StatesTafamidis Drugs Revenue Growth 2019-2024 ($ millions)
Figure 42. CanadaTafamidis Drugs Revenue Growth 2019-2024 ($ millions)
Figure 43. MexicoTafamidis Drugs Revenue Growth 2019-2024 ($ millions)
Figure 44. BrazilTafamidis Drugs Revenue Growth 2019-2024 ($ millions)
Figure 45. APACTafamidis Drugs Sales Market Share by Region in 2023
Figure 46. APACTafamidis Drugs Revenue Market Share by Region (2019-2024)
Figure 47. APACTafamidis Drugs Sales Market Share byType (2019-2024)
Figure 48. APACTafamidis Drugs Sales Market Share by Application (2019-2024)
Figure 49. ChinaTafamidis Drugs Revenue Growth 2019-2024 ($ millions)
Figure 50. JapanTafamidis Drugs Revenue Growth 2019-2024 ($ millions)
Figure 51. South KoreaTafamidis Drugs Revenue Growth 2019-2024 ($ millions)
Figure 52. Southeast AsiaTafamidis Drugs Revenue Growth 2019-2024 ($ millions)
Figure 53. IndiaTafamidis Drugs Revenue Growth 2019-2024 ($ millions)
Figure 54. AustraliaTafamidis Drugs Revenue Growth 2019-2024 ($ millions)
Figure 55. ChinaTaiwanTafamidis Drugs Revenue Growth 2019-2024 ($ millions)
Figure 56. EuropeTafamidis Drugs Sales Market Share by Country in 2023
Figure 57. EuropeTafamidis Drugs Revenue Market Share by Country (2019-2024)
Figure 58. EuropeTafamidis Drugs Sales Market Share byType (2019-2024)
Figure 59. EuropeTafamidis Drugs Sales Market Share by Application (2019-2024)
Figure 60. GermanyTafamidis Drugs Revenue Growth 2019-2024 ($ millions)
Figure 61.FranceTafamidis Drugs Revenue Growth 2019-2024 ($ millions)
Figure 62. UKTafamidis Drugs Revenue Growth 2019-2024 ($ millions)
Figure 63. ItalyTafamidis Drugs Revenue Growth 2019-2024 ($ millions)
Figure 64. RussiaTafamidis Drugs Revenue Growth 2019-2024 ($ millions)
Figure 65. Middle East & AfricaTafamidis Drugs Sales Market Share by Country (2019-2024)
Figure 66. Middle East & AfricaTafamidis Drugs Sales Market Share byType (2019-2024)
Figure 67. Middle East & AfricaTafamidis Drugs Sales Market Share by Application (2019-2024)
Figure 68. EgyptTafamidis Drugs Revenue Growth 2019-2024 ($ millions)
Figure 69. South AfricaTafamidis Drugs Revenue Growth 2019-2024 ($ millions)
Figure 70. IsraelTafamidis Drugs Revenue Growth 2019-2024 ($ millions)
Figure 71.TurkeyTafamidis Drugs Revenue Growth 2019-2024 ($ millions)
Figure 72. GCC CountriesTafamidis Drugs Revenue Growth 2019-2024 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis ofTafamidis Drugs in 2023
Figure 74. Manufacturing Process Analysis ofTafamidis Drugs
Figure 75. Industry Chain Structure ofTafamidis Drugs
Figure 76. Channels of Distribution
Figure 77. GlobalTafamidis Drugs Sales MarketForecast by Region (2025-2030)
Figure 78. GlobalTafamidis Drugs Revenue Market ShareForecast by Region (2025-2030)
Figure 79. GlobalTafamidis Drugs Sales Market ShareForecast byType (2025-2030)
Figure 80. GlobalTafamidis Drugs Revenue Market ShareForecast byType (2025-2030)
Figure 81. GlobalTafamidis Drugs Sales Market ShareForecast by Application (2025-2030)
Figure 82. GlobalTafamidis Drugs Revenue Market ShareForecast by Application (2025-2030)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tafamidis Drugs Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Tafamidis Drugs by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Tafamidis Drugs by Country/Region, 2019, 2023 & 2030
2.2 Tafamidis Drugs Segment by Type
2.2.1 Tafamidis Free Acid
2.2.2 Tafamidis Meglumine
2.3 Tafamidis Drugs Sales by Type
2.3.1 Global Tafamidis Drugs Sales Market Share by Type (2019-2024)
2.3.2 Global Tafamidis Drugs Revenue and Market Share by Type (2019-2024)
2.3.3 Global Tafamidis Drugs Sale Price by Type (2019-2024)
2.4 Tafamidis Drugs Segment by Application
2.4.1 ATTR-PN
2.4.2 ATTR-CM
2.4.3 Other
2.5 Tafamidis Drugs Sales by Application
2.5.1 Global Tafamidis Drugs Sale Market Share by Application (2019-2024)
2.5.2 Global Tafamidis Drugs Revenue and Market Share by Application (2019-2024)
2.5.3 Global Tafamidis Drugs Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Tafamidis Drugs Breakdown Data by Company
3.1.1 Global Tafamidis Drugs Annual Sales by Company (2019-2024)
3.1.2 Global Tafamidis Drugs Sales Market Share by Company (2019-2024)
3.2 Global Tafamidis Drugs Annual Revenue by Company (2019-2024)
3.2.1 Global Tafamidis Drugs Revenue by Company (2019-2024)
3.2.2 Global Tafamidis Drugs Revenue Market Share by Company (2019-2024)
3.3 Global Tafamidis Drugs Sale Price by Company
3.4 Key Manufacturers Tafamidis Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tafamidis Drugs Product Location Distribution
3.4.2 Players Tafamidis Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TAFAMIDIS DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Tafamidis Drugs Market Size by Geographic Region (2019-2024)
4.1.1 Global Tafamidis Drugs Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Tafamidis Drugs Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Tafamidis Drugs Market Size by Country/Region (2019-2024)
4.2.1 Global Tafamidis Drugs Annual Sales by Country/Region (2019-2024)
4.2.2 Global Tafamidis Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas Tafamidis Drugs Sales Growth
4.4 APAC Tafamidis Drugs Sales Growth
4.5 Europe Tafamidis Drugs Sales Growth
4.6 Middle East & Africa Tafamidis Drugs Sales Growth
5 AMERICAS
5.1 Americas Tafamidis Drugs Sales by Country
5.1.1 Americas Tafamidis Drugs Sales by Country (2019-2024)
5.1.2 Americas Tafamidis Drugs Revenue by Country (2019-2024)
5.2 Americas Tafamidis Drugs Sales by Type (2019-2024)
5.3 Americas Tafamidis Drugs Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tafamidis Drugs Sales by Region
6.1.1 APAC Tafamidis Drugs Sales by Region (2019-2024)
6.1.2 APAC Tafamidis Drugs Revenue by Region (2019-2024)
6.2 APAC Tafamidis Drugs Sales by Type (2019-2024)
6.3 APAC Tafamidis Drugs Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Tafamidis Drugs by Country
7.1.1 Europe Tafamidis Drugs Sales by Country (2019-2024)
7.1.2 Europe Tafamidis Drugs Revenue by Country (2019-2024)
7.2 Europe Tafamidis Drugs Sales by Type (2019-2024)
7.3 Europe Tafamidis Drugs Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tafamidis Drugs by Country
8.1.1 Middle East & Africa Tafamidis Drugs Sales by Country (2019-2024)
8.1.2 Middle East & Africa Tafamidis Drugs Revenue by Country (2019-2024)
8.2 Middle East & Africa Tafamidis Drugs Sales by Type (2019-2024)
8.3 Middle East & Africa Tafamidis Drugs Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tafamidis Drugs
10.3 Manufacturing Process Analysis of Tafamidis Drugs
10.4 Industry Chain Structure of Tafamidis Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tafamidis Drugs Distributors
11.3 Tafamidis Drugs Customer
12 WORLD FORECAST REVIEW FOR TAFAMIDIS DRUGS BY GEOGRAPHIC REGION
12.1 Global Tafamidis Drugs Market Size Forecast by Region
12.1.1 Global Tafamidis Drugs Forecast by Region (2025-2030)
12.1.2 Global Tafamidis Drugs Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Tafamidis Drugs Forecast by Type (2025-2030)
12.7 Global Tafamidis Drugs Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Tafamidis Drugs Product Portfolios and Specifications
13.1.3 Pfizer Tafamidis Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Qilu pharmaceutical
13.2.1 Qilu pharmaceutical Company Information
13.2.2 Qilu pharmaceutical Tafamidis Drugs Product Portfolios and Specifications
13.2.3 Qilu pharmaceutical Tafamidis Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Qilu pharmaceutical Main Business Overview
13.2.5 Qilu pharmaceutical Latest Developments
13.3 Chia Tai Tianqing Pharmaceutical
13.3.1 Chia Tai Tianqing Pharmaceutical Company Information
13.3.2 Chia Tai Tianqing Pharmaceutical Tafamidis Drugs Product Portfolios and Specifications
13.3.3 Chia Tai Tianqing Pharmaceutical Tafamidis Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Chia Tai Tianqing Pharmaceutical Main Business Overview
13.3.5 Chia Tai Tianqing Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1.Tafamidis Drugs Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2.Tafamidis Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players ofTafamidisFree Acid
Table 4. Major Players ofTafamidis Meglumine
Table 5. GlobalTafamidis Drugs Sales byType (2019-2024) & (K Units)
Table 6. GlobalTafamidis Drugs Sales Market Share byType (2019-2024)
Table 7. GlobalTafamidis Drugs Revenue byType (2019-2024) & ($ million)
Table 8. GlobalTafamidis Drugs Revenue Market Share byType (2019-2024)
Table 9. GlobalTafamidis Drugs Sale Price byType (2019-2024) & (US$/Unit)
Table 10. GlobalTafamidis Drugs Sale by Application (2019-2024) & (K Units)
Table 11. GlobalTafamidis Drugs Sale Market Share by Application (2019-2024)
Table 12. GlobalTafamidis Drugs Revenue by Application (2019-2024) & ($ million)
Table 13. GlobalTafamidis Drugs Revenue Market Share by Application (2019-2024)
Table 14. GlobalTafamidis Drugs Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. GlobalTafamidis Drugs Sales by Company (2019-2024) & (K Units)
Table 16. GlobalTafamidis Drugs Sales Market Share by Company (2019-2024)
Table 17. GlobalTafamidis Drugs Revenue by Company (2019-2024) & ($ millions)
Table 18. GlobalTafamidis Drugs Revenue Market Share by Company (2019-2024)
Table 19. GlobalTafamidis Drugs Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key ManufacturersTafamidis Drugs Producing Area Distribution and Sales Area
Table 21. PlayersTafamidis Drugs Products Offered
Table 22.Tafamidis Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. GlobalTafamidis Drugs Sales by Geographic Region (2019-2024) & (K Units)
Table 26. GlobalTafamidis Drugs Sales Market Share Geographic Region (2019-2024)
Table 27. GlobalTafamidis Drugs Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. GlobalTafamidis Drugs Revenue Market Share by Geographic Region (2019-2024)
Table 29. GlobalTafamidis Drugs Sales by Country/Region (2019-2024) & (K Units)
Table 30. GlobalTafamidis Drugs Sales Market Share by Country/Region (2019-2024)
Table 31. GlobalTafamidis Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. GlobalTafamidis Drugs Revenue Market Share by Country/Region (2019-2024)
Table 33. AmericasTafamidis Drugs Sales by Country (2019-2024) & (K Units)
Table 34. AmericasTafamidis Drugs Sales Market Share by Country (2019-2024)
Table 35. AmericasTafamidis Drugs Revenue by Country (2019-2024) & ($ millions)
Table 36. AmericasTafamidis Drugs Sales byType (2019-2024) & (K Units)
Table 37. AmericasTafamidis Drugs Sales by Application (2019-2024) & (K Units)
Table 38. APACTafamidis Drugs Sales by Region (2019-2024) & (K Units)
Table 39. APACTafamidis Drugs Sales Market Share by Region (2019-2024)
Table 40. APACTafamidis Drugs Revenue by Region (2019-2024) & ($ millions)
Table 41. APACTafamidis Drugs Sales byType (2019-2024) & (K Units)
Table 42. APACTafamidis Drugs Sales by Application (2019-2024) & (K Units)
Table 43. EuropeTafamidis Drugs Sales by Country (2019-2024) & (K Units)
Table 44. EuropeTafamidis Drugs Revenue by Country (2019-2024) & ($ millions)
Table 45. EuropeTafamidis Drugs Sales byType (2019-2024) & (K Units)
Table 46. EuropeTafamidis Drugs Sales by Application (2019-2024) & (K Units)
Table 47. Middle East & AfricaTafamidis Drugs Sales by Country (2019-2024) & (K Units)
Table 48. Middle East & AfricaTafamidis Drugs Revenue Market Share by Country (2019-2024)
Table 49. Middle East & AfricaTafamidis Drugs Sales byType (2019-2024) & (K Units)
Table 50. Middle East & AfricaTafamidis Drugs Sales by Application (2019-2024) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities ofTafamidis Drugs
Table 52. Key Market Challenges & Risks ofTafamidis Drugs
Table 53. Key IndustryTrends ofTafamidis Drugs
Table 54.Tafamidis Drugs Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56.Tafamidis Drugs Distributors List
Table 57.Tafamidis Drugs Customer List
Table 58. GlobalTafamidis Drugs SalesForecast by Region (2025-2030) & (K Units)
Table 59. GlobalTafamidis Drugs RevenueForecast by Region (2025-2030) & ($ millions)
Table 60. AmericasTafamidis Drugs SalesForecast by Country (2025-2030) & (K Units)
Table 61. AmericasTafamidis Drugs Annual RevenueForecast by Country (2025-2030) & ($ millions)
Table 62. APACTafamidis Drugs SalesForecast by Region (2025-2030) & (K Units)
Table 63. APACTafamidis Drugs Annual RevenueForecast by Region (2025-2030) & ($ millions)
Table 64. EuropeTafamidis Drugs SalesForecast by Country (2025-2030) & (K Units)
Table 65. EuropeTafamidis Drugs RevenueForecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & AfricaTafamidis Drugs SalesForecast by Country (2025-2030) & (K Units)
Table 67. Middle East & AfricaTafamidis Drugs RevenueForecast by Country (2025-2030) & ($ millions)
Table 68. GlobalTafamidis Drugs SalesForecast byType (2025-2030) & (K Units)
Table 69. GlobalTafamidis Drugs RevenueForecast byType (2025-2030) & ($ millions)
Table 70. GlobalTafamidis Drugs SalesForecast by Application (2025-2030) & (K Units)
Table 71. GlobalTafamidis Drugs RevenueForecast by Application (2025-2030) & ($ millions)
Table 72. Pfizer Basic Information,Tafamidis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 73. PfizerTafamidis Drugs Product Portfolios and Specifications
Table 74. PfizerTafamidis Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Pfizer Main Business
Table 76. Pfizer Latest Developments
Table 77. Qilu pharmaceutical Basic Information,Tafamidis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 78. Qilu pharmaceuticalTafamidis Drugs Product Portfolios and Specifications
Table 79. Qilu pharmaceuticalTafamidis Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Qilu pharmaceutical Main Business
Table 81. Qilu pharmaceutical Latest Developments
Table 82. ChiaTaiTianqing Pharmaceutical Basic Information,Tafamidis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. ChiaTaiTianqing PharmaceuticalTafamidis Drugs Product Portfolios and Specifications
Table 84. ChiaTaiTianqing PharmaceuticalTafamidis Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. ChiaTaiTianqing Pharmaceutical Main Business
Table 86. ChiaTaiTianqing Pharmaceutical Latest Developments
LIST OFFIGURES
Figure 1. Picture ofTafamidis Drugs
Figure 2.Tafamidis Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. GlobalTafamidis Drugs Sales Growth Rate 2019-2030 (K Units)
Figure 7. GlobalTafamidis Drugs Revenue Growth Rate 2019-2030 ($ millions)
Figure 8.Tafamidis Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9.Tafamidis Drugs Sales Market Share by Country/Region (2023)
Figure 10.Tafamidis Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture ofTafamidisFree Acid
Figure 12. Product Picture ofTafamidis Meglumine
Figure 13. GlobalTafamidis Drugs Sales Market Share byType in 2023
Figure 14. GlobalTafamidis Drugs Revenue Market Share byType (2019-2024)
Figure 15.Tafamidis Drugs Consumed in ATTR-PN
Figure 16. GlobalTafamidis Drugs Market: ATTR-PN (2019-2024) & (K Units)
Figure 17.Tafamidis Drugs Consumed in ATTR-CM
Figure 18. GlobalTafamidis Drugs Market: ATTR-CM (2019-2024) & (K Units)
Figure 19.Tafamidis Drugs Consumed in Other
Figure 20. GlobalTafamidis Drugs Market: Other (2019-2024) & (K Units)
Figure 21. GlobalTafamidis Drugs Sale Market Share by Application (2023)
Figure 22. GlobalTafamidis Drugs Revenue Market Share by Application in 2023
Figure 23.Tafamidis Drugs Sales by Company in 2023 (K Units)
Figure 24. GlobalTafamidis Drugs Sales Market Share by Company in 2023
Figure 25.Tafamidis Drugs Revenue by Company in 2023 ($ millions)
Figure 26. GlobalTafamidis Drugs Revenue Market Share by Company in 2023
Figure 27. GlobalTafamidis Drugs Sales Market Share by Geographic Region (2019-2024)
Figure 28. GlobalTafamidis Drugs Revenue Market Share by Geographic Region in 2023
Figure 29. AmericasTafamidis Drugs Sales 2019-2024 (K Units)
Figure 30. AmericasTafamidis Drugs Revenue 2019-2024 ($ millions)
Figure 31. APACTafamidis Drugs Sales 2019-2024 (K Units)
Figure 32. APACTafamidis Drugs Revenue 2019-2024 ($ millions)
Figure 33. EuropeTafamidis Drugs Sales 2019-2024 (K Units)
Figure 34. EuropeTafamidis Drugs Revenue 2019-2024 ($ millions)
Figure 35. Middle East & AfricaTafamidis Drugs Sales 2019-2024 (K Units)
Figure 36. Middle East & AfricaTafamidis Drugs Revenue 2019-2024 ($ millions)
Figure 37. AmericasTafamidis Drugs Sales Market Share by Country in 2023
Figure 38. AmericasTafamidis Drugs Revenue Market Share by Country (2019-2024)
Figure 39. AmericasTafamidis Drugs Sales Market Share byType (2019-2024)
Figure 40. AmericasTafamidis Drugs Sales Market Share by Application (2019-2024)
Figure 41. United StatesTafamidis Drugs Revenue Growth 2019-2024 ($ millions)
Figure 42. CanadaTafamidis Drugs Revenue Growth 2019-2024 ($ millions)
Figure 43. MexicoTafamidis Drugs Revenue Growth 2019-2024 ($ millions)
Figure 44. BrazilTafamidis Drugs Revenue Growth 2019-2024 ($ millions)
Figure 45. APACTafamidis Drugs Sales Market Share by Region in 2023
Figure 46. APACTafamidis Drugs Revenue Market Share by Region (2019-2024)
Figure 47. APACTafamidis Drugs Sales Market Share byType (2019-2024)
Figure 48. APACTafamidis Drugs Sales Market Share by Application (2019-2024)
Figure 49. ChinaTafamidis Drugs Revenue Growth 2019-2024 ($ millions)
Figure 50. JapanTafamidis Drugs Revenue Growth 2019-2024 ($ millions)
Figure 51. South KoreaTafamidis Drugs Revenue Growth 2019-2024 ($ millions)
Figure 52. Southeast AsiaTafamidis Drugs Revenue Growth 2019-2024 ($ millions)
Figure 53. IndiaTafamidis Drugs Revenue Growth 2019-2024 ($ millions)
Figure 54. AustraliaTafamidis Drugs Revenue Growth 2019-2024 ($ millions)
Figure 55. ChinaTaiwanTafamidis Drugs Revenue Growth 2019-2024 ($ millions)
Figure 56. EuropeTafamidis Drugs Sales Market Share by Country in 2023
Figure 57. EuropeTafamidis Drugs Revenue Market Share by Country (2019-2024)
Figure 58. EuropeTafamidis Drugs Sales Market Share byType (2019-2024)
Figure 59. EuropeTafamidis Drugs Sales Market Share by Application (2019-2024)
Figure 60. GermanyTafamidis Drugs Revenue Growth 2019-2024 ($ millions)
Figure 61.FranceTafamidis Drugs Revenue Growth 2019-2024 ($ millions)
Figure 62. UKTafamidis Drugs Revenue Growth 2019-2024 ($ millions)
Figure 63. ItalyTafamidis Drugs Revenue Growth 2019-2024 ($ millions)
Figure 64. RussiaTafamidis Drugs Revenue Growth 2019-2024 ($ millions)
Figure 65. Middle East & AfricaTafamidis Drugs Sales Market Share by Country (2019-2024)
Figure 66. Middle East & AfricaTafamidis Drugs Sales Market Share byType (2019-2024)
Figure 67. Middle East & AfricaTafamidis Drugs Sales Market Share by Application (2019-2024)
Figure 68. EgyptTafamidis Drugs Revenue Growth 2019-2024 ($ millions)
Figure 69. South AfricaTafamidis Drugs Revenue Growth 2019-2024 ($ millions)
Figure 70. IsraelTafamidis Drugs Revenue Growth 2019-2024 ($ millions)
Figure 71.TurkeyTafamidis Drugs Revenue Growth 2019-2024 ($ millions)
Figure 72. GCC CountriesTafamidis Drugs Revenue Growth 2019-2024 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis ofTafamidis Drugs in 2023
Figure 74. Manufacturing Process Analysis ofTafamidis Drugs
Figure 75. Industry Chain Structure ofTafamidis Drugs
Figure 76. Channels of Distribution
Figure 77. GlobalTafamidis Drugs Sales MarketForecast by Region (2025-2030)
Figure 78. GlobalTafamidis Drugs Revenue Market ShareForecast by Region (2025-2030)
Figure 79. GlobalTafamidis Drugs Sales Market ShareForecast byType (2025-2030)
Figure 80. GlobalTafamidis Drugs Revenue Market ShareForecast byType (2025-2030)
Figure 81. GlobalTafamidis Drugs Sales Market ShareForecast by Application (2025-2030)
Figure 82. GlobalTafamidis Drugs Revenue Market ShareForecast by Application (2025-2030)
